The Capital Group's ownership dependences are as follows:
- HTL-STREFA S.A. located in Ozorkow, Poland - parent company
- HT Lancet Sp. z o.o. located in Leczyca, Poland
- HTL-STREFA Marketing Sp. z o.o. located in Warsaw, Poland
- HTL-STREFA, Inc. located in Marietta, GA, USA,
- HTL-STREFA GmbH located in Frankfurt am Main, Germany,
- HaeMedic AB located in Tyresö, Sweden,
- HaeMedic Polska Sp. z o.o. located in Ozorkow, Poland.
HTL-STREFA S.A. manufactures personal and safety lancets (also in clean zone conditions) and moulds needles. Company's duties also include quality control of all products made by capital group and logistics.
Entered in the Company Register by the Lodz - Srodmiescie District Court in Lodz, 10th Commercial Division of the National Court Register, KRS Register no. 0000256309, VAT no. 732-18-80-362, REGON: 472350579. Share and paid–in capital – PLN 645,937,31.
HT Lancet Sp. z o.o. manufactures plastic components used for safety and personal lancets. In IIIQ 2007 this company opened their own needle grinding facility. These needles will be utilized in personal and safety lancets manufacturing.
HTL-STREFA Marketing Sp. z o.o. supports key account management mainly on foreign markets.
Entered in the National Court Register no. 0000260811; REGON: 140607191. Share & paid-in capital: PLN 700.000,00
HTL-STREFA, Inc. supports other units in managing US key accounts and develops sales on American “alternative” markets.
HTL-STREFA GmbH supports sales of group products on European market.
HaeMedic AB is the owner of trade marks and other intellectual property rights related to
manufacturing of several safety lancets.
HaeMedic Polska Sp. z o.o. is owner of machines and equipment to Haemolance and Prolance safety lancets manufacturing.
HTL Group organization chart
